ClinicalTrials.gg
RecruitingNCT07945743Updated Nov 18, 2026

Muscle Synergy-Inspired Functional Electrical Stimulation for Rehabilitating Hand Motor Functions Post-Stroke

An interventional study of Functional electrical stimulation in Stroke, sponsored by Chinese University of Hong Kong. Recruiting at 1 site in China. Open to participants aged 18 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-18.

Sponsored by Chinese University of Hong Kong · Not applicable, Interventional, and Treatment

Updated Nov 18, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-18

Among 54 studies in Stroke by Chinese University of Hong Kong — 20 open to participants now, 21 under way, none of them phase 3. Stroke · Chinese University of Hong Kong.

Planned enrollment
26th of 41
50 · median 64
Started
2026
with 1 other
No phase
38 of 54
15 open now
Primary completion
2027-12
later than 10 of 20 live
Registered
54th of 54
by date

Among the 54 studies in Stroke by Chinese University of Hong Kong, this one is the 26th largest by planned enrollment of the 41 interventional ones that give a count, is one of 2 that started in 2026, is one of 38 with no phase, reaches primary completion later than 10 of the 20 other live ones, and was the 54th registered.

Stroke

8,279 studies on the registry are indexed under Stroke; 2,067 are open to participants now.

Browse Stroke studies →

Open to participants now

20 of the 54 studies in Stroke by Chinese University of Hong Kong are open now, in 4 countries. Recruiting first, the newest first:

14 more — sign in →

By country, each count listing its studies:

All 20 open studies →

Where they have run

Who these studies take

Of the 1,421 Stroke studies recruiting now, 696 (49%) set no upper age limit and 284 (20%) stop at 75 or younger; 77 take children under 18; 198 take healthy volunteers.

This study: 18 Years to 80 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 54 studies in Stroke by Chinese University of Hong Kong, or all of them as a file.
02

Study summary

The goal of this clinical trial is to learn whether muscle-synergy-based functional electrical stimulation works to improve upper limb motor function in stroke subjects. The main questions it aims to answer are:

Does muscle-synergy inspired FES strategy help participant get better motor recovery?

Participants will:

Receive FES or sham stimulation to the affected arm for 30 minutes a day, for 5 sessions.

Continue their usual rehabilitation programme throughout the study. Record clinical assessments and high-density EMGs before and after the treatment.

Read the detailed description

Unilateral stroke survivors (N=50) will be recruited and randomly assigned to one of two groups, which will receive usual rehabilitation care only, and usual care plus functional electrical stimulation (FES) training, respectively. Each subject will be evaluated before (T0), after (T1) intervention. At T0, clinical scores (Fugl-Meyer assessment, Brunnstrom stage), video recordings of hand movement, and high-density EMGs will be applied on the patients' forearm to assess the motor functions. At T1, clinical scores, video recordings, and high-density EMGs will be assessed again for characterizing post-rehab functional gain and recovery. Treatments will last ≥5 training sessions depending on the inpatient stay days. All T0 and T1 data will be analyzed offline with muscle synergy analysis and motor unit decomposition analysis.

Clinical scores. Clinical assessments will be conducted at both T0 and T1 to characterize upper extremity motor impairment and evaluate changes in motor recovery between the two assessment time points. Two complementary clinical measures will be used: (1) the Fugl-Meyer Assessment for Upper Extremity (FMA-UE) and (2) the Brunnstrom Stages of Motor Recovery.

The FMA-UE will be used to quantify motor impairment of the affected upper extremity. It assesses reflex activity, voluntary movements within and outside synergistic patterns, wrist and hand motor function, and coordination and movement speed. The motor score ranges from 0 to 66, with higher scores indicating less severe motor impairment. This assessment provides a structured characterization of residual motor abilities and difficulties in selective movement control and is widely used in clinical stroke rehabilitation. Changes in FMA-UE scores between T0 and T1 will be used to quantify changes in upper extremity motor impairment.

The Brunnstrom Stages will be used to characterize the stage of motor recovery following stroke. This assessment describes recovery patterns ranging from flaccidity and limited voluntary movement to the emergence of synergistic movements and, subsequently, more selective and coordinated voluntary control. It complements the FMA-UE by providing an ordinal classification of motor recovery, with particular emphasis on the presence of abnormal synergies and the ability to perform movements independently of these patterns. Comparisons between T0 and T1 will indicate whether participants have progressed to a more advanced recovery stage.

The two assessments are expected to take approximately 30 minutes in total at each time point. Participants' basic demographic characteristics, comorbidities, and other relevant medical conditions will be retrieved from their medical records to characterize the study population and provide clinical context for interpreting the assessment results.

Hand Kinematics recording. Hand kinematic recording. Hand kinematics will be assessed at T0 and T1 using a markerless, multi-camera recording system to quantify extension performance and selective finger control under FES-on and FES-off conditions. The emphasis on extension is motivated by the prognostic relevance of early voluntary finger extension for subsequent upper limb recovery after stroke (Nijland et al., 2010). Extension performance and finger individuation will be evaluated separately, as strength and selective finger control represent distinguishable dimensions of post-stroke hand recovery (Xu et al., 2017). Previous studies have demonstrated the feasibility of video-based markerless assessment of finger movements and upper limb reaching in individuals with stroke (Choudhury et al., 2025; Suwabe et al., 2024).

Participants will be seated comfortably, with the affected forearm supported in pronation, the palm facing downward, and the hand initially in a relaxed resting posture. The support will be arranged to allow unrestricted finger and wrist extension. The initial wrist and finger positions will be documented before each trial, and the forearm position and support configuration will be reproduced across conditions and assessment sessions. Following a standardized verbal cue, participants will perform five tasks: (1) simultaneous extension of all five digits to open the hand; (2) selective thumb extension; (3) selective index finger extension; (4) simultaneous extension of the middle, ring, and little fingers; and (5) wrist extension. Participants will attempt to maintain the achieved position for 5 s before returning to the resting posture. During tasks 2-4, they will be instructed to keep the non-target digits as still as possible without external restraint. During finger tasks, participants will also be instructed to minimize wrist movement and forearm rotation. Each task will be repeated five times per condition, with rest periods between trials to limit fatigue. Condition order will be counterbalanced across participants.

Three USB cameras will be positioned at complementary angles around the hand, with each camera configured to acquire video at 1280 × 720 pixels, in YUYV format, at 60 frames per second. OBS Studio will control recording initiation and termination, and the three camera feeds will be recorded within a single scene using a fixed layout that preserves the native resolution of each view. Camera positions, focus, and lighting will remain unchanged during calibration and task recording. Intrinsic and extrinsic camera parameters will be estimated using a calibration board of known dimensions. Inter-camera timing offsets and temporal stability will be checked using a visual timing signal visible in all views, because simultaneous recording within an OBS scene does not establish hardware synchronization. Stimulation onset and offset will be documented relative to the video timeline.

Offline processing will combine DeepLabCut for two-dimensional landmark detection with Anipose for three-dimensional reconstruction (Karashchuk et al., 2021; Mathis et al., 2018). Composite videos will be separated into individual camera views using fixed crop coordinates, with identical processing applied to calibration recordings. A DeepLabCut model will be trained or fine-tuned using annotated frames covering different participants, hand postures, camera views, and stimulation conditions. Landmarks on the forearm, wrist, hand, and digits will be tracked, and temporally aligned detections will be triangulated using Anipose. Joint angles and digit movements will be calculated relative to anatomical segment coordinate systems to reduce the influence of whole-hand translation and rotation. Tracking accuracy will be evaluated using held-out annotated frames, reprojection errors, and visual inspection. Filtering, short-gap interpolation, and exclusion criteria will be specified before outcome analysis.

Kinematic outcomes will include joint extension excursion, peak extension velocity, maximum continuous holding duration, and unintended movement of non-target digits. Extension task success will be defined as reaching the prespecified task-specific joint-angle targets within the allowed response period and maintaining them continuously for 5 s without prohibited assistance or compensatory movement. For tasks 2-4, selective extension success will additionally require non-target digit movements to remain within predefined tolerances throughout the movement and holding phases. Target angles, response periods, and movement tolerances will be established through pilot testing, considering measurement error, passive range of motion, and physiological finger coupling, and will be fixed before the main study (Lang and Schieber, 2004). Task success rates will be calculated separately for each task and condition as the number of successful trials divided by the number of assessable trials, multiplied by 100%. Unsuccessful movement attempts will remain in the denominator, whereas technically unassessable trials will be documented separately. FES-on versus FES-off comparisons will characterize immediate stimulation-assisted performance, while changes in FES-off performance between T0 and T1 will characterize changes in voluntary motor performance.

High-density EMGs recording. High-density surface electromyography (HD-sEMG) will be recorded at T0 and T1 to characterize forearm muscle activity during voluntary hand and wrist movements without FES. HD-sEMG enables the assessment of the spatial distribution of muscle electrical activity across the skin surface (Gallina et al., 2022). Signals will be acquired using a TMSi recording system at a sampling rate of 2048 Hz, synchronized with the three-camera kinematic recording system.

Two customized flexible electrode arrays will be positioned around the middle third of the affected forearm. Each array will contain 64 recording channels arranged into eight longitudinal electrode columns (threads), with eight electrodes per thread and a longitudinal interelectrode spacing of 1 cm. Channels 1-64 will cover the palmar aspect of the forearm, while channels 65-128 will cover the dorsal aspect, providing 128 recording channels distributed across 16 threads around the forearm circumference. The spacing between adjacent threads will vary according to forearm circumference. A measuring tape will guide placement to distribute the threads as evenly as possible, and the position of the first thread will be marked on the skin to guide consistent array alignment across assessments.

During recording, participants will be seated with the affected forearm supported in pronation, the palm facing downward, and the hand initially in a relaxed resting posture. Participants will perform five tasks in a fixed sequence: (1) simultaneous extension of all five digits; (2) selective thumb extension; (3) selective index finger extension; (4) simultaneous extension of the middle, ring, and little fingers; and (5) wrist extension. For each task, participants will attempt to maintain the achieved position for 5 s before returning to the resting posture. During selective digit tasks, participants will be instructed to minimize movement of the non-target digits without external restraint. The five-task sequence will be repeated eight times, yielding eight trials per task and 40 trials per assessment session. This predictable sequence is intended to reduce cognitive demands and distribute repetitions of each task across the recording session rather than requiring consecutive repetitions of the same movement. EMG and video recordings will include unsuccessful movement attempts as well as successfully completed trials.

03

Conditions studied

  • Stroke

Browse trials for

Keywords

  • High-density EMGs
  • Muscle synergies
  • Functional electrical stimulation
04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Unilateral stroke
  • Normal Cognition

Exclusion criteria

Exclusion Criteria:

  • Bilateral stroke
  • Upper limb injury
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Care provider)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Apply personalized functional electrical stimulation based on high-density EMG assessment

    Other: Functional electrical stimulation

  • Sham comparator
    Apply functional electrical stimulation that targets dorsal forearm

    Other: Functional electrical stimulation

Interventions

  • OtherFunctional electrical stimulation

    Apply personalized functional electrical stimulation to upper limb of stroke patients

06

What researchers measure

Primary outcomes

  1. Fugl-Meyer assessment - upper extremity

    Two-stage of assessment including pre-assessment and post-assessment

    Time frame: Two weeks

  2. High-density EMG assessment

    High-density EMG assessment

    Time frame: two weeks

07

Study locations

1 of 1 sites recruiting
  • Guangdong Work Injury Rehabilitation Hospital
    Guangzhou, Guangdong, China
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Nov 2026; primary completion for Dec 2027, 13 months later.

Of 3,120 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's planned 13 months is below that.

Counting every sponsor, half of 3,264 studies reached it within 23 months; a quarter within 10 and three quarters within 46.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 13, 2026
First posted
Nov 18, 2026
StartEst.
Nov 16, 2026
Primary completionEst.
Dec 30, 2027
CompletionEst.
Apr 15, 2028
Last update
Nov 18, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 18, 2026
Show all 1 update
  1. Nov 18, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07945743
Collaborators
Shenzhen Institutes of Advanced Technology ,Chinese Academy of Sciences
Responsible party
Cheung Chi Kwan Vincent (Professor, Chinese University of Hong Kong) — Principal investigator
First posted
Nov 18, 2026
Start date
Nov 16, 2026 (estimated)
Primary completion
Dec 30, 2027 (estimated)
Completion
Apr 15, 2028 (estimated)
Last update
Nov 18, 2026

Study contacts

Minglei Bai, Doctor of Philosophy
Contact
mingleibai@cuhk.edu.hk
+8613172460636
Vincent Cheung, Doctor of Philosophy
principal investigator · The Chinese University of Hong Kong, Gerald Choa Neuroscience Institute

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion